sahpra
Dapivirine vaginal ring: increasing SA’s HIV arsenal
The dapivirine vaginal ring will soon be available to women and young girls at limited pilot sites from June. The South African Health Products Regulatory Authority (SAHPRA) approved its use by women ages 18 and older to reduce their…
World Aids Day: Injectable PrEP adds to arsenal
With South Africa expected to begin piloting injectable Pre-Exposure Prophylaxis (PrEP) early next year, experts have described the proposed rollout as a potential ‘game changer’ in the fight against the virus. It is primed to provide an additional HIV…
Slow rollout for child-friendly ARV treatment
South African children will have to wait until next year for the rollout of the child friendly, ‘sweet-tasting’ antiretroviral (ARV) treatment, despite this new 4-in-1 combination receiving the green light. The South African Health Products Regulatory Authority (SAHPRA) approved the…
SAHPRA confirms COVID-19 jab related death
A recipient of the COVID-19 Johnson & Johnson vaccine booster has died, as confirmed by the South African Health Products and Regulatory Authority (SAHPRA) earlier today. Since the start of the pandemic, this is South Africa’s first casualty out of…
COVID-19 vaccines: South Africans urged to report adverse events
The South African Health Products Regulatory Authority (SAHPRA) has urged South Africans to report adverse effects experienced due to COVID-19 vaccines. This call comes at a time when reporting of such events has hit a low in the country. Florah…
Dapivirine vaginal ring: SA rollout put on ice for now
South African women will have to wait before laying their hands on the newly-approved dapivirine vaginal ring (DPV-VR – while the National Department of Health assesses the effectiveness of the HIV prevention device. Department of Health (DOH) spokesperson, Foster Mohale,…
Pfizer has applied to have its COVID-19 vaccine used as a booster in SA
The South African Health Regulatory Products Authority (SAHPRA) on Monday confirmed that Pfizer has applied to have its coronavirus vaccine used as a booster in the country. In a statement released Monday afternoon, SAPHRA said it would now assess the…